Zhuanghui P. Hao

Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma.

A bibliometric analysis of the research landscape of lenalidomide resistance in multiple myeloma.

Journal: Discover oncology

Published: February 24, 2026

Interpretable machine learning model using peripheral blood for non-invasive detection of moderate-to-severe myelofibrosis in JAK2 V617F-positive MPNs: A multicentre pilot proof-of-concept study.

Interpretable machine learning model using peripheral blood for non-invasive detection of moderate-to-severe myelofibrosis in JAK2 V617F-positive MPNs: A multicentre pilot proof-of-concept study.

Journal: British journal of haematology

Published: February 06, 2026

The miR4261/PAMM axis in multiple myeloma promotes bone resorption.

The miR4261/PAMM axis in multiple myeloma promotes bone resorption.

Journal: Scientific reports

Published: December 22, 2025

Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients.

Dominant TET2 mutations predict adverse prognosis in cytogenetically normal acute myeloid leukemia patients.

Journal: Frontiers in oncology

Published: October 23, 2025

Metformin attenuates placental oxidative stress through Nrf2/Keap1 signaling in preeclampsia rats.

Metformin attenuates placental oxidative stress through Nrf2/Keap1 signaling in preeclampsia rats.

Journal: Archives of biochemistry and biophysics

Published: July 28, 2025

Differential impact of IDH1/2 mutations on outcome in adult acute myeloid leukemia patients.

Differential impact of IDH1/2 mutations on outcome in adult acute myeloid leukemia patients.

Journal: Cancer genetics

Published: June 06, 2025

Synergy Between second-generation FLT3 inhibitors and the ERK1/2 inhibitor Ulixertinib in FLT3-ITD-mutated acute myeloid leukemia (AML) cells.

Synergy Between second-generation FLT3 inhibitors and the ERK1/2 inhibitor Ulixertinib in FLT3-ITD-mutated acute myeloid leukemia (AML) cells.

Journal: Medical oncology (Northwood, London, England)

Published: June 03, 2025

Autophagy in PE: Dispute, Role and Potential Target.

Autophagy in PE: Dispute, Role and Potential Target.

Journal: Cell proliferation

Published: March 31, 2025

Adhesion of Immunoglobulins to Band3 Promotes Increased Erythrocyte Sedimentation Rate in Multiple Myeloma.

Adhesion of Immunoglobulins to Band3 Promotes Increased Erythrocyte Sedimentation Rate in Multiple Myeloma.

Journal: Cell proliferation

Published: March 25, 2025

Human umbilical cord mesenchymal stem cells improve bone marrow hematopoiesis through regulation of bone marrow adipose tissue.

Human umbilical cord mesenchymal stem cells improve bone marrow hematopoiesis through regulation of bone marrow adipose tissue.

Journal: Molecular and cellular biochemistry

Published: July 02, 2024

MiR-4261 targeted YWHAE/CAST/GPX1 impairs the calcium regulatory function of PMCA4 in erythrocytes of myeloma.

MiR-4261 targeted YWHAE/CAST/GPX1 impairs the calcium regulatory function of PMCA4 in erythrocytes of myeloma.

Journal: Indian journal of pathology & microbiology

Published: April 08, 2024

Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.

Immunophenotype of myeloid granulocytes in Chinese patients with BCR::ABL1-negative myeloproliferative neoplasms.

Journal: Clinical and experimental medicine

Published: March 21, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026